woops...
EBITDA for full year to 30/6/09 may be $70+M, which will be 56% growth over the previous year...
- Forums
- ASX - By Stock
- COF
- oversold
oversold, page-11
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add COF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.22 |
Change
0.000(0.00%) |
Mkt cap ! $725.7M |
Open | High | Low | Value | Volume |
$1.23 | $1.24 | $1.22 | $443.9K | 362.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4648 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 16996 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 32803 | 1.215 |
16 | 34370 | 1.210 |
10 | 19864 | 1.205 |
9 | 42731 | 1.200 |
2 | 7482 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.220 | 2434 | 10 |
1.225 | 41468 | 13 |
1.230 | 80395 | 13 |
1.235 | 18230 | 8 |
1.240 | 10358 | 6 |
Last trade - 14.01pm 15/07/2024 (20 minute delay) ? |
Featured News
COF (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online